<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://alive528.com/videoEmbed/26375/del-bigtree-an-inconvenient-study" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Del Bigtree AN INCONVENIENT STUDY

WINNER BEST OF FESTIVAL MALIBU FILM FESTIVAL 2025 Premiere October 12

00:09:52

FHD

Kiki

1 year 6 Du kan ikke administrere denne video

Del Bigtree Inconvenient Study Vaccine

Del Log ind for at donere Rapport 0

Permanent Link

Stream url (SEO)

Nuværende tid (SEO)

Kategori:

PODCAST

Beskrivelse:

Del's Take Executive Producer, Del Bigtree, introduces the official trailer for 'An Inconvenient Study.'
In 2016, journalist Del Bigtree issued a challenge to the head of infectious disease at one of the most prestigious medical institutions in the world: conduct the most thorough vaxxed vs. unvaxxed study that has ever been done. The expert took up the challenge and ran the study to prove Del wrong. That study never saw the light of day... until now.

watch full movie
https://alive528.com/video/26364

Kommentarer

{imgURL}
{title}
{channelName}

{category_name}

Open toolbar

Increase Text Decrease Text Grayscale High Contrast Negative Contrast Links Underline Readable Font Nulstil

Verify Email Address

Enter Code (Code will expire in 05:00) * Code will only last 5 minutes

02:00 to resend

Your index is currently INACTIVE.

Please check your platform contents to make sure it doesn't violate the terms and condition before indexing.

Terms and Conditions

already exist

Enter new Engine Name

Share

Del Bigtree AN INCONVENIENT STUDY

WINNER BEST OF FESTIVAL MALIBU FILM FESTIVAL 2025 Premiere October 12

Embed Options

Kommentarer

Verify Email Address

02:00 to resend

Your index is currently INACTIVE. Please check your platform contents to make sure it doesn't violate the terms and condition before indexing.

Terms and Conditions

Your index is currently INACTIVE.

Please check your platform contents to make sure it doesn't violate the terms and condition before indexing.